GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Centessa Pharmaceuticals PLC (STU:260) » Definitions » FCF Yield %

Centessa Pharmaceuticals (STU:260) FCF Yield % : -15.42 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Centessa Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Centessa Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-138.56 Mil, and Market Cap is €881.71 Mil. Therefore, Centessa Pharmaceuticals's FCF Yield % for today is -15.42%.

The historical rank and industry rank for Centessa Pharmaceuticals's FCF Yield % or its related term are showing as below:

STU:260' s FCF Yield % Range Over the Past 10 Years
Min: -24.35   Med: -15.84   Max: -13.25
Current: -15.42


During the past 5 years, the highest FCF Yield % of Centessa Pharmaceuticals was -13.25%. The lowest was -24.35%. And the median was -15.84%.

STU:260's FCF Yield % is ranked worse than
51.42% of 1554 companies
in the Biotechnology industry
Industry Median: -14.335 vs STU:260: -15.42

Centessa Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


Centessa Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Centessa Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centessa Pharmaceuticals FCF Yield % Chart

Centessa Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - - -66.91 -20.99

Centessa Pharmaceuticals Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.79 -31.91 -24.79 -16.25 -13.66

Competitive Comparison of Centessa Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Centessa Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centessa Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Centessa Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Centessa Pharmaceuticals's FCF Yield % falls into.



Centessa Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Centessa Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-147.189 / 701.30108
=-20.99%

Centessa Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-34.303 * 4 / 1004.82
=-13.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centessa Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Centessa Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Centessa Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Centessa Pharmaceuticals (STU:260) Business Description

Traded in Other Exchanges
Address
1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Centessa Pharmaceuticals (STU:260) Headlines

No Headlines